Exhibit 458 ยท Warning letter
Warning Letter to The Jim Bakker Show (MARCS-CMS 604820)
In addition, it is unlawful under the FTC Act, 15 U.S.C. 41 et seq., to advertise that a product can prevent, treat, or cure human disease unless you possess competent and reliable scientific evidence, including, when appropriate, well-controlled human clinical studies, substantiating that the claims are true at the time they are made
Joint letter on silver products marketed for COVID-19. A warning letter, not a court order.
- Source
- U.S. Food and Drug Administration and Federal Trade Commission
- Date
- 6 March 2020
- Quoted from
- FTC paragraph near end of letter
- Grade
- Primary record
- Document
- https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/jim-bakker-show-604820-03062020
- Accessed
- 2026-11-09
- Cited by
- Findings citing this exhibit
- Note
- The FTC took part through this joint letter. No FTC court action was found.